Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy

Background/Aims For metastatic renal cell carcinoma (RCC), various prognostic scoring systems have been developed. However, owing to the low prevalence of nonclear cell RCC, the three most commonly used tools were mainly developed based on patients with clear cell histology. Accordingly, this study...

Full description

Bibliographic Details
Main Authors: In Hee Lee, Byung Woog Kang, Jong Gwang Kim, Woo Kyun Bae, Myung Seo Ki, Inkeun Park, Jae-Cheol Jo, Jin Young Kim, Sung Ae Koh, Kyung Hee Lee, Yoon Young Cho, Hun Mo Ryoo, Sang Gyu Kwak, Jung Lim Lee, Sun Ah Lee
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2020-01-01
Series:The Korean Journal of Internal Medicine
Subjects:
non-clear cell renal cell carcinoma
temsirolimus
prognostic model
survival
Online Access:http://www.kjim.org/upload/pdf/kjim-2018-064.pdf

Internet

http://www.kjim.org/upload/pdf/kjim-2018-064.pdf

Similar Items